These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2787315)

  • 41. [131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication.
    Hoefnagel CA; Schornagel J; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):308-12. PubMed ID: 1823843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
    Rose B; Matthay KK; Price D; Huberty J; Klencke B; Norton JA; Fitzgerald PA
    Cancer; 2003 Jul; 98(2):239-48. PubMed ID: 12872341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A new medico-nuclear outlook for the diagnosis and treatment of pheochromocytomas: 131I-meta-iodobenzylguanidine (131I-MIBG). Comments on results obtained].
    Troncone L; Rufini V; Danza FM; Valenza V; Montemaggi P; Bonifazi N
    Radiol Med; 1986 Jun; 72(6):485-94. PubMed ID: 3715090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma.
    Sudbrock F; Schmidt M; Simon T; Eschner W; Berthold F; Schicha H
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1279-90. PubMed ID: 20179922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results of [131I]metaiodobenzylguanidine treatment in metastatic malignant phaeochromocytoma.
    Bestagno M; Pizzocaro C; Maira G; Terzi A; Panarotto MB; Guerra P
    J Nucl Biol Med (1991); 1991; 35(4):277-9. PubMed ID: 1823835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: a French multicenter study.
    Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
    J Nucl Biol Med (1991); 1991; 35(4):284-7. PubMed ID: 1823837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 131I-metaiodobenzylguanidine--a new agent for scintigraphic imaging and treatment of pheochromocytoma.
    Fischer M; Vetter W; Winterberg B; Vetter H
    Nuklearmedizin; 1984 Apr; 23(2):77-9. PubMed ID: 6473116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
    Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
    Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pheochromocytoma: diagnosis by scintigraphy using iodine 131 metaiodobenzylguanidine.
    Campeau RJ; Garcia OM; Correa OA; Rege AB
    South Med J; 1991 Oct; 84(10):1221-30. PubMed ID: 1925724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.
    Voûte PA; Hoefnagel CA; de Kraker J
    Bull Cancer; 1988; 75(1):107-11. PubMed ID: 3359053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapy of pheochromocytoma with [131I]metaiodobenzylguanidine.
    Fischer M
    J Nucl Biol Med (1991); 1991; 35(4):292-4. PubMed ID: 1823839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
    Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
    Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis and treatment of phaeochromocytoma with 131I-metaiodobenzylguanidine.
    Fischer M; Vetter W; Winterberg B; Zidek W; Hengstmann J; Vetter H
    J Hypertens Suppl; 1984 Dec; 2(3):S187-9. PubMed ID: 6599667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [131I]metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma.
    Lumbroso J; Schlumberger M; Tenenbaum F; Aubert B; Travagli JP; Parmentier C
    J Nucl Biol Med (1991); 1991; 35(4):288-91. PubMed ID: 1823838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication.
    Lynn MD; Shapiro B; Sisson JC; Swanson DP; Mangner TJ; Wieland DM; Meyers LJ; Glowniak JV; Beierwaltes WH
    J Nucl Med; 1984 Apr; 25(4):436-40. PubMed ID: 6544815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Malignant pheochromocytoma treated by I-131 MIBG.
    McDougall IR
    J Nucl Med; 1984 Feb; 25(2):249-51. PubMed ID: 6726433
    [No Abstract]   [Full Text] [Related]  

  • 57. [131-iodine meta-iodobenzylguanidine scintigraphy and therapy in malignant pheochromocytoma].
    Kessel F; Hahn K; Eissner D; Beyer J; Thelen M
    Internist (Berl); 1986 Jan; 27(1):70-3. PubMed ID: 3514518
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.
    Fukuoka M; Taki J; Mochizuki T; Kinuya S
    Clin Nucl Med; 2011 Jan; 36(1):1-7. PubMed ID: 21157198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SPECT quantitation of iodine-131 concentration in phantoms and human tumors.
    Israel O; Iosilevsky G; Front D; Bettman L; Frenkel A; Ish-Shalom S; Steiner M; Ben-Harush M; Kolodny GM
    J Nucl Med; 1990 Dec; 31(12):1945-9. PubMed ID: 2266390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytoma.
    Lewington VJ; Zivanovic MA; Tristam M; McEwan AJ; Ackery DM
    J Nucl Biol Med (1991); 1991; 35(4):280-3. PubMed ID: 1823836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.